ORIGINAL RESEARCH article

Front. Genet., 08 August 2025

Sec. Genetics of Common and Rare Diseases

Volume 16 - 2025 | https://doi.org/10.3389/fgene.2025.1624122

Identification and splicing analysis of the first deep intronic FIG4 variant causing Yunis–Varon syndrome

  • Center for Reproduction and Genetics, School of Gusu, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China

Abstract

Yunis–Varón syndrome (YVS) is a severe autosomal recessive syndrome caused by mutations in the FIG4 gene. It is characterized by skeletal defects, including cleidocranial dysplasia and digital anomalies, and a poor prognosis due to neurological and cardiovascular involvement. In this study, we observed a Chinese family with three patients presenting thumb and hallux dysplasia. Whole-genome sequencing (WGS) identified a compound heterozygous variant in the proband: c.2097-809A>G and c.1141C>T (p.R381*). The c.2097-809A>G variant generated an aberrant splicing transcript containing a pseudoexon from intron 18, as demonstrated by further RT-PCR and splicing analysis. This is the first deep intronic variant reported in the FIG4 gene. In addition, we provided prenatal diagnoses for the family. This study expands the genetic variant spectrum, provides additional molecular and clinical information, and broadens our understanding of the molecular mechanisms involved in the disease course.

1 Introduction

Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) is one of the seven known phosphoinositides involved in the orchestration of vesicle trafficking in mammalian cells (). The FIG4 gene encodes a phosphoinositide 5-phosphatase that regulates the synthesis and turnover of PI(3,5)P2 and is involved in endolysosomal trafficking (; ; ). Variants in FIG4 can cause four different diseases: bilateral temporo-occipital polymicrogyria (OMIM 612691), amyotrophic lateral sclerosis 11 (OMIM 612577), Charcot–Marie–Tooth disease, type 4J (CMT4J) (OMIM 611228), and Yunis–Varón syndrome (YVS) (OMIM 216340). In an animal model, homozygous FIG4-null mice exhibit neurological features of YVS, including degeneration of the brain and peripheral ganglia and enlarged vacuoles in neurons; they also present skeletaldeformities, with reduced trabecular bone volume and cortical thickness, and accumulate large vacuoles (; ; ).

Yunis–Varón syndrome is a very rare autosomal recessive syndrome that exhibits severe skeletal abnormalities (cleidocranial dysplasia, absence/hypoplasia of thumbs and halluces, pelvic bone dysplasia, and fractures), which are often lethal in infancy (; ). In addition, neurological features such as hypotonia, dysphagia, global developmental delay, brain malformations, retinopathy, and facial dysmorphisms have also been attributed to it (; ). By describing and reviewing the literature, some studies of FIG4-associated YVS have been reported (; ; ; ; ; ). However, only a few of them carried out appropriate genetic analysis and diagnosis. Variant analysis of the FIG4 gene is a valuable tool for screening and diagnosis of YVS. So far, we have found 18 variants of YVS that have been recorded: c.350C>T, c.2376 + 1G>T (), c.573del, c.2174dup (), c.1260_1261del, c.311G>A, c.831_838del, c.524T>C (), c.968A>G (), c.1750+1del, c.2285_2286del (), c.1141C>T, c.2459+1G>A, c.1294C>T, c.122T>C, c.1474C>T, c.2285_2286del, and c.1583+1G>T (). All of them have severe clinical features of YVS, such as skeletal abnormalities, craniofacial dysmorphisms, and structural brain anomalies. We also observed prenatal phenotypes in the fetuses.

In this study, we report the identification of a novel deep intronic FIG4 variant (c.2097-809A>G) in a Chinese family with three neonates presenting hallmark features of YVS. The c.2097-809A>G variant, the first deep intronic variant reported in the FIG4 gene, was identified by whole-genome sequencing (WGS) and confirmed by Sanger sequencing. Further splicing analysis of RNA from peripheral blood mononuclear cells (PBMCs) demonstrated that c.2097-809A>G generated an aberrant transcript that destroyed the function of FIG4. Therefore, we provided prenatal diagnosis for this family. This study expands the genetic variant spectrum, provides additional molecular and clinical information, and broadens our understanding of the molecular mechanisms involved in the disease course.

2 Methods

2.1 Participants and ethical statement

This study included three children from a Chinese family who received geneticcounseling at Suzhou Municipal Hospital in 2022. Written informed consent was obtained from the patients’ parents, and all procedures were conducted in accordance with the tenets of the Declaration of Helsinki. The research was performed under the approval of the Ethics Committee of Suzhou Municipal Hospital, the Affiliated Suzhou Hospital of Nanjing Medical University (approval no. 2017005).

2.2 DNA and RNA isolation

We obtained blood samples from a child, his parents, and normal controls and the amniotic fluid from the fetus. A younger afflictedchild died soon after birth, and we could not collect his samples. Genomic DNA was extracted using the QIAamp DNA Blood Mini Kit (QIAGEN, Hilden, Germany), according to the standard extraction methods. Total RNA from the blood leukocytes of the patients and controls was extracted using the standard TRIzol method. cDNAs were synthesized from RNA using the RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Waltham, United States).

2.3 Whole-genome sequencing

Qualified genomic DNA was randomly fragmented into proper pieces (350 bp). WGS libraries were prepared using the MGIEasy FS DNA Prep kit (BGI, Beijing, China), according to the manufacturer’s instructions. Then, they were sequenced using DNBSEQ-T7 (MGI, Beijing, China). The minimal read depth was 30-fold for WGS. Quality control for the paired-end reads was assessed using FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/), and fastp () was used for adapter trimming and quality filtering.

2.4 Variant analysis by direct sequencing

Direct Sanger sequencing in both directions was conducted to validate putative variants. The sequence containing the variant was amplified by polymerase chain reaction (PCR) with the primers FIG4 exon 11 (forward, 5′- GGA​TTT​GAA​CCC​AGG​CAG​TAC​T-3′ and reverse, 5′-TCG​CTG​ATC​TCC​CAA​AAC​TTA​CT-3′) and FIG4 intron 18 (forward, 5′- ACT​GTT​AGT​GGT​TTT​GGT​CCT-3′ and reverse, 5′-TGT​TGA​TTT​CTG​CTC​AGG​GA-3′). PCR products were verified by agarose gel electrophoresis and subsequently sequenced in both directions using an ABI 3130 Genetic Analyzer (Applied Biosystems, United States).

2.5 Reverse transcription polymerase chain reaction and TA cloning

After extracting total RNA from the neonate and healthy controls, cDNAs were synthesized from RNA using the RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, United States). DNA fragments of FIG4 intron 18 were amplified with the following primers: forward, 5′- TCC​TGG​GAG​TTT​TCC​ATC​CCA​CT-3′ and reverse, 5′-CTG​GCT​GCC​GTT​TTC​CGC​TG-3′. The expected PCR product size was 451 bp. TA cloning was performed to isolate the aberrant transcript. PCR amplification was ligated to the T-Vector pMD19 (Simple) (TaKaRa, Japan). The positive clones were selected by blue/white screening with β-gal selection, and plasmids were extracted from the enriched white isolations using the Plasmid Mini Kit (QIAGEN, Hilden, Germany). For each sample, 10 bacterial clones were sequenced. The sequence of the amplified segment was compared with the reference sequence at UCSC.

2.6 Prenatal diagnosis

Following the identification and analysis of the FIG4 variant in the family members, prenatal genetic testing was performed for the fetus. In brief, an amniotic fluid sample was collected under ultrasonic guidance from the proband at 22 weeks of gestation. DNA was extracted using a DNA extraction kit (TIANGEN Biotech, Beijing, China), according to the manufacturer’s instructions. The FIG4 gene variant was detected using the same methods as previously described.

3 Results

3.1 Clinical features

The patient (II-2) was a 16-day-old newborn at the time of genetic consultation in 2022. He was born through cesarean section with mild asphyxia, weak crying, dysphagia, feeding difficulties, and neonatal hypotonia. He exhibited multiple facial deformities, such as a broad forehead, long philtrum, hypertelorism, depressed nasal bridge, low ear position, retrognathia, short neck, and yellow hair. His bilateral, extremely short thumbs and bigtoes are notable characteristics of YVS (Figure 1A). He also developed hypospadias. The echocardiography also showed an atrial septal defect and atrial septal aneurysm. His mother had an earlier child in 2019 (II-1) with similar defects. The 24-week ultrasound results showed multiple malformations, including a dilated fourth ventricle, posterior fossa cyst, low conus medullaris position with coccyx curvature abnormality, persistent left superior vena cava, slightly enlarged right heart, and a small amount of pericardial effusion (2.3 mm) (Figure 1B). After birth, he presented with abnormal skull morphology, metopic synostosis, and dyspnea. His hypoplastic thumbs and big toes were identical to those of II-2, and he died shortly thereafter. The parents denied consanguinity and any family history of related conditions (Figure 2A).

FIGURE 1

FIGURE 2

3.2 Identification of the variant

To examine the variant, we performed WGS using DNA from the proband and his parents’ PBMCs. The average depth of WGS was 30×, and the percentage of coverage over 10× was 96.4%, meeting the qualification for subsequent analysis. After filtering the variants using the minor allele frequency (MAF) in the 1000 Genomes Project and the Genome Aggregation Database (gnomAD) and searching for suspicious variants by the characteristic phenotype, c.1141C>T(p.R381*) in FIG4 was identified as being inherited from the mother. c.1141C>T (p.R381*) has been reported in two children with early-onset CMT4J (; ). In addition, the clinical findings of the two patients were highly suggestive of YVS caused by pathogenic variants in FIG4. Next, an in-depth search and analysis were performed. Then, we found c.2097-809A>G in the proband, which was inherited from the father. c.2097-809A>G was absent in various genetic variant databases or websites such as the ClinVar Database, Human Gene Variant Database (HGMD), Leiden Open Variation Database (LOVD), and PubMed. The online website SpliceAI predicted that it would destroy the acceptor sites with a score of 0.97. Subsequent family genotyping from his parents confirmed the compound heterozygous forms (Figure 2B).

3.3 RT-PCR and splicing analysis

RT-PCR of FIG4 exons 16 to 20 in mRNAs from the patient displayed an aberrant splicing transcript of 579 bp in addition to a 451-bp wild-type product (Figure 3A). Afterward, TA cloning was carried out, and cDNA sequencing results showed that the longer abnormal transcript comprised a 128-bp pseudo-exon from intron 18 (FIG4: c.2097-808_ 2097-681) (Figures 3B, C), resulting in a frameshift and generating a premature termination codon at residue 822 (p.Asp700Valfs*123).

FIGURE 3

3.4 Prenatal diagnosis of the FIG4 gene

In 2024, the mother was pregnant with her second child. We employed Sanger sequencing for amniotic fluid sample prenatal testing and identified that the fetus also unfortunately had compound heterozygous variants of c.2097-809A>G and c.1141C>T in the FIG4 gene (Figure 2B). Prenatalultrasound showed a low conus medullaris position and an expanded rightlateralventricle (Figure 1C). Furthermore, SNP-array results showed that it was a female fetus. After genetic counseling, the couple chose to abort the child. After obtaining consent from the parents, we observed some phenotypes in the aborted fetus, such as low ear position and dysplasia of thumbs and halluces (Figure 1D). The parents may undergo pre-implantation genetic testing for monogenic disorders (PGT-M) for the next child.

4 Discussion

In the era of rapid sequencing technology, whole-genome sequencing has become a powerful tool for identifying candidate variants and enabling appropriate diagnoses—especially when pathogenic variants are concealed in patients with the typical phenotype and cannot be detected by routine exonic DNA sequencing methods such as Sanger sequencing or whole-exome sequencing. In this study, we detected a compound heterozygous variant in FIG4: c.1141C>T (p.R381*) and c.2097-809A>G by WGS. c.2097-809A>G is the first deep intronic variant in the FIG4 gene associated with Yunis–Varon syndrome.

Yunis–Varón syndrome is caused by complete loss-of-function of FIG4 and is characterized by severe neurological anomalies, cleidocranial dysplasia, and digital anomalies (). Other frequently reported malformations include a wide fontanelle with diastasis of cranial sutures, sparse scalp hairs, microcephaly, ectodermal malformations, bilateral hip dislocation, genital abnormalities, and central nervous system abnormalities such as Dandy–Walker malformation, agenesis of the corpus callosum, hydrocephalus, and hypoplastic vermis (). Cardiovascular abnormalities such as ventricularhypertrophy and tetralogy of Fallot have also been reported (; ). The dysmorphic features observed in our three patients were consistentwith those reported previously.

Introns are very important for eukaryotic evolution. The identification of genes with correct exon–intron architecture plays an important role in eukaryotic genome annotation (), and alternative splicing is crucial for the enhancement of transcriptome and proteome diversity (). Nowadays, WGS has greatly improved the diagnosis of genetic diseases and increased the number of pathogenic deep intronic variants. These deleterious deep intronic variants usually generate pseudo-exon inclusion by the activation of atypical splice sites or changes in splicing regulatory elements ().

In the present study, we identified two variants in FIG4: c.1141C>T (p.R381*) inherited from the mother and c.2097-809A>G inherited from the father in the proband. His affected brother had a similar phenotype, but unfortunately, we could not obtain his sample to confirm the molecular results. c.1141C>T causes a premature termination codon at position 381 and has been reported in two children with early-onset CMT4J. c.2097-809A>G may destroy the acceptor sites predicted by SpliceAI. Subsequently, RT-PCR of FIG4 in the patient’s mRNAs displays an aberrant splicing transcript of 579 bp compared to a 451-bp wild-type product (Figure 3A) that hinted at a pseudo-exon inclusion in FIG4. We identified a 128-bp pseudo-exon from intron 18 (FIG4: c.2097-808_ 2097-681) in the mutant type by RT-PCR analysis and TA cloning. We put the full sequence of FIG4 containing the pseudo-exon into EditSeq software, and the translated protein presented a frameshift and resulted in a premature termination codon at residue 822 (p.Asp700Valfs*123). p.Asp700Valfs*123 is predicted to cause loss-of-function of the protein as a frameshift truncating mutation, resulting in an altered protein that lacks the C-terminal residues of the wild-type FIG4 protein responsible for membrane anchoring (). Nonsense-mediated mRNA decay is likely to occur because the variants remove more than 10% of the protein. After 1 year, the mother was pregnant again. Prenatal diagnosis showed that her second child also had compound heterozygous variants in FIG4. In addition, the aborted fetus exhibited a low conus medullaris position, an expanded rightlateralventricle, a low ear position, and dysplasia of thumbs and halluces. Unfortunately, the family had another YVS patient because of c.2097-809A>G and c.1141C>T in the FIG4 gene. According to the ACMG variant classification guideline, c.1141C>T could be classified as pathogenic (PVS1, PM3, PM2_Supporting, PP1, and PP4), and c.2097-809A>G could also be classified as pathogenic (PVS1, PM2_Supporting, PM3, PP1, and PP4). Notably, c.2097-809A>G appeared to be the first deep intronic variant in the FIG4 gene associated with YVS (Figure 4).

FIGURE 4

To date, 18 variants of YVS have been described in previous publications and are shown in Figure 4. Of them, 61.1% (11 of 18) are loss-of-function variants, including 1 nonsense variant, 5 frameshift variants, and 5 splicing variants. c.122T>C p.(Ile41Thr), c.1474C>T p.(Arg492Cys), c.968A>G p.(Gln323Arg), c.311G>A(p.Gly104Asp), and c.524T>C alter highly conserved amino acid residues located at important domains and are predicted to affect FIG4 function (; ; ). In those cases, 10 patients had prenatal ultrasound manifestations (Table 1). The most frequent clinical feature in fetuses (60%, 6 of 10) is structural brain anomalies such as dilated ventricles and Dandy–Walker malformation rather than limb abnormalities (>75% of cases) (). Only two children (20%, 2 of 10) had absent thumbs or halluces because of a low prenatal detection rate in prenatal evaluation (). The affected individuals also presented with other manifestations, such as fetal pyelectasis, fetal hydrops, and growth retardation. It is worth noting that two patients in our study had abnormalities that have not been previously reported: a posterior fossa cyst and a low conus medullaris position with coccyx curvature abnormality. All of the cases were found in the third trimester, except one in the second trimester, which demonstrates a significant barrier to early diagnosis and intervention for patients’ families.

TABLE 1

ReferenceFamilial relationshipVariantGenderPostnatal evolutionPrenatal ultrasound finding
One affected childc.350C>T and c.2376 + 1G>TNA19WA dilated ventricle and fetal pyelectasis
One affected childc.573del, and c.2174dupNA24WScaphocephaly, absence of bilateral thumbs, hypospadias, pericardial effusion, and umbilical cord cyst
One affected childNAFNAHydrocephalus with Dandy–Walker malformation
One affected childc.1750+1del and c.2285_2286delFNAIntrauterine growth retardation
One affected childNAM30WFetal growth retardation and microcephaly
One affected childNAF37WFetal hydrops and polyhydramnios
Two affected siblingsNAFNANA
NAF29WAbsent thumbs and big toes
One affected childc.968A>GM35WSevere oligohydramnios
This studyTwo affected siblingsNAM24WA dilated fourth ventricle, a posterior fossa cyst, low conus medullaris position with coccyx curvature abnormality, persistent left superior vena cava, slightly enlarged right heart, and a small amount of pericardial effusion
c.1141C>T and c.2097-809A>GMNANA
c.1141C>T and c.2097-809A>GF23WLow conus medullaris position and an expanded right lateral ventricle

Summary of prenatal ultrasound clinical findings in YVS.

F, female; M, male; NA, not assessed.

Pathogenic deep intronic variants have been reported in more than 100 disease-associated genes. Given that the deep intronic variants identified in the present study could be detected using whole-genome sequencing and RT-PCR and splicing analysis are usually used to validate variants that have an effect on splicing in a molecular diagnostic setting (; ), in this study, we used WGS to effectively detect deep intronic variants that have been widely employed in the diagnosis of genetic diseases. We detected the first deep intronic variant (c.2097-809A>G) in FIG4. Pathogenicity analysis of deep intronic variants in FIG4 can improve the genetic diagnosis rate of YVS and highlight the importance of screening of non-coding regions with functional assays to decipher the hidden variant in YVS. At the same time, in this family, spinal deformity was observed as a new phenotype in YVS. However, the small sample size is quite a limitation to our study. Therefore, additional efforts on large cohort studies are urgently needed to better clarify the genotype–phenotype correlation and provide refined genetic counseling.

5 Conclusion

We detected the first deep intronic variant in FIG4 (c.2097-809A>G) in a Chinese family with three neonates presenting the hallmark features of YVS, thereby linking this variant to the syndrome and expanding the unknown geneticvariantspectrum. The splicing analysis shows how c.2097-809A>G influences the transcript and contributes to YVS. This study provides additional molecular and clinical information and broadens our understanding of the molecular mechanisms involved in the disease course.

Statements

Data availability statement

The datasets presented in this article are not readily available to assure patient confidentiality and participant privacy. Requests to access the datasets should be directed to .

Ethics statement

The studies involving humans were approved by the Ethics Committee of the Suzhou Municipal Hospital, the Affiliated Suzhou Hospital of Nanjing Medical University. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants’ legal guardians/next of kin. Written informed consent was obtained from the individual(s) and minor(s)’ legal guardian/next of kin for the publication of any potentially identifiable images or data included in this article.

Author contributions

HT: Investigation, Writing – original draft, Conceptualization. QC: Data curation, Writing – review and editing, Resources, Formal Analysis. JX: Supervision, Writing – review and editing. QZ: Formal Analysis, Writing – review and editing, Resources, Data curation.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Primary Research and Development Plan of Jiangsu Province (BE2022736) and the Jiangsu Maternal and Child Healthcare Key Discipline (FXK202142).

Acknowledgments

The authors thank the coordinators from the Chigene (Beijing) Translational Medical Research Center Co., Ltd., for sequencing technology support.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1

    Abdul Wahab SiddiqueZ. A.Ammar HaiderH. K.KarimT. (2019). Yunis-varon syndrome. J. Ayub Med. Coll. Abbottabad31 (2), 290–292.

  • 2

    AdèsL. C.MorrisL. L.RichardsonM.PearsonC.HaanE. A. (1993). Congenital heart malformation in Yunis-Varón syndrome. J. Med. Genet.30 (9), 788–792. 10.1136/jmg.30.9.788

  • 3

    Basel-VanagaiteL.KornreichL.SchillerO.YacobovichJ.MerlobP. (2008). Yunis-Varon syndrome: further delineation of the phenotype. Am. J. Med. Genet.146A (4), 532–537. 10.1002/ajmg.a.32135

  • 4

    Beauregard-LacroixÉ.ScottA.NguyenT.WierengaK. J.PurcarinG.KarstensenA. B.et al (2024). Exploring the phenotypic spectrum and osteopenia mechanisms in Yunis-Varón syndrome. Genet. Med. open2, 2101837. 10.1016/j.gimo.2024.101837

  • 5

    CampeauP. M.LenkG. M.LuJ. T.BaeY.BurrageL.TurnpennyP.et al (2013). Yunis-Varón syndrome is caused by mutations in FIG4, encoding a phosphoinositide phosphatase. Am. J. Hum. Genet.92 (5), 781–791. 10.1016/j.ajhg.2013.03.020

  • 6

    ChenS.ZhouY.ChenY.GuJ. (2018). Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics34 (17), i884–i890. 10.1093/bioinformatics/bty560

  • 7

    ChowC. Y.ZhangY.DowlingJ. J.JinN.AdamskaM.ShigaK.et al (2007). Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature448 (7149), 68–72. 10.1038/nature05876

  • 8

    Corona-RiveraJ. R.Romo-HuertaC. O.López-MarureE.RamosF. J.Estrada-PadillaS. A.Zepeda-RomeroL. C. (2011). New ocular findings in two sisters with Yunis-Varón syndrome and literature review. Eur J Med Genet.54(1):76–81. 10.1016/j.ejmg.2010.09.013

  • 9

    FergusonC. J.LenkG. M.JonesJ. M.GrantA. E.WintersJ. J.DowlingJ. J.et al (2012). Neuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration. Hum. Mol. Genet.21 (16), 3525–3534. 10.1093/hmg/dds179

  • 10

    KerenH.Lev-MaorG.AstG. (2010). Alternative splicing and evolution: diversification, exon definition and function. Nat. Rev. Genet.11 (5), 345–355. 10.1038/nrg2776

  • 11

    LeesJ. A.LiP.KumarN.WeismanL. S.ReinischK. M. (2020). Insights into lysosomal PI(3,5)P2 homeostasis from a structural-biochemical analysis of the PIKfyve lipid kinase complex. Mol. Cell80 (4), 736–743.e4. 10.1016/j.molcel.2020.10.003

  • 12

    MartynC.LiJ. (2013). Fig4 deficiency: a newly emerged lysosomal storage disorder. Prog. Neurobiol.101-102, 35–45. 10.1016/j.pneurobio.2012.11.001

  • 13

    MishraA.SiwachP.MisraP.DhimanS.PandeyA. K.SrivastavaP.et al (2021). Intron exon boundary junctions in human genome have in-built unique structural and energetic signals. Nucleic Acids Res.49 (5), 2674–2683. 10.1093/nar/gkab098

  • 14

    NakajimaJ.OkamotoN.ShiraishiJ.NishimuraG.NakashimaM.TsurusakiY.et al (2013). Novel FIG4 mutations in Yunis-Varon syndrome. J. Hum. Genet.58 (12), 822–824. 10.1038/jhg.2013.104

  • 15

    NicholsonG.LenkG. M.ReddelS. W.GrantA. E.TowneC. F.FergusonC. J.et al (2011). Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P2 phosphatase FIG4. Brain134 (Pt 7), 1959–1971. 10.1093/brain/awr148

  • 16

    PengY.YangS.HuangX.PangJ.LiuJ.HuJ.et al (2021). Whole exome sequencing analysis in fetal skeletal dysplasia detected by ultrasonography: an analysis of 38 cases. Front. Genet.12, 12728544. 10.3389/fgene.2021.728544

  • 17

    ReutterH.BagciS.MüllerA.GembruchU.GeipelA.BergC.et al (2012). Primary pulmonary hypertension, congenital heart defect, central nervous system malformations, hypo- and aplastic toes: another case of Yunis-Varón syndrome or report of a new entity. Eur. J. Med. Genet.55 (1), 27–31. 10.1016/j.ejmg.2011.09.002

  • 18

    SbrissaD.IkonomovO. C.FuZ.IjuinT.GruenbergJ.TakenawaT.et al (2007). Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel sac phosphatase joins the ArPIKfyve-PIKfyve complex. J. Biol. Chem.282 (33), 23878–23891. 10.1074/jbc.M611678200

  • 19

    SumiM.KusumotoT.KondohT.MoriuchiH.MiyamotoM.MasuzakiH.et al (2004). A case of Yunis-Varon syndrome complicated with complete cleft lip and palate. Am J Med Genet A. 125A(1):92–3. 10.1002/ajmg.a.20414

  • 20

    UmairM.AlkharfyT. M.SajjadS.AlfadhelM. (2021). FIG4-Associated Yunis-Varon syndrome: identification of a novel missense variant. Mol. Syndromol.12 (6), 386–392. 10.1159/000516971

  • 21

    Vaz-DragoR.CustódioN.Carmo-FonsecaM. (2017). Deep intronic mutations and human disease. Hum. Genet.136 (9), 1093–1111. 10.1007/s00439-017-1809-4

  • 22

    VijN.GoncalvesL. F.LlanesA.YounS.BelthurM. V. (2023). Prenatal radiographic evaluation of congenital transverse limb deficiencies: a scoping review. World J. Orthop.14 (3), 155–165. 10.5312/wjo.v14.i3.155

  • 23

    WalchE.SchmidtM.BrennerR. E.EmonsD.DameC.PontzB.et al (2000). Yunis-Varon syndrome: evidence for a lysosomal storage disease. Am J Med Genet.95(2):157–60. 10.1002/1096-8628(20001113)95:2<157::aid-ajmg12>3.0.co;2-e

  • 24

    WangY.YinF.ChaiY.JinJ.ZhangP.TanQ.et al (2023). Prenatal diagnosis of fetuses with ultrasound anomalies by whole-exome sequencing in Luoyang city, China. Front. Genet.14, 141301439. 10.3389/fgene.2023.1301439

  • 25

    YunisE.VaronH. (1980). Cleidocranial dysostosis, severe micrognathism, bilateral absence of thumbs and first metatarsal bone, and distal aphalangia a new genetic syndrome. Am. J. Dis. Child., 134649–134653.

  • 26

    ZhangC.YanY.ZhouB.WangY.TianX.HaoS.et al (2023). Identification of deep intronic variants of PAH in phenylketonuria using full-length gene sequencing. Orphanet J. Rare Dis.18 (1), 128. 10.1186/s13023-023-02742-1

  • 27

    ZimmermannM.SchusterS.BoeschS.KorenkeG. C.MohrJ.ReichbauerJ.et al (2020). FIG4 mutations leading to parkinsonism and a phenotypical continuum between CMT4J and Yunis Varón syndrome. Park. Relat. Disord.74, 746–11. 10.1016/j.parkreldis.2020.03.021

Summary

Keywords

Yunis–Varón syndrome, FIG4 gene, deep intronic variant, whole-genome sequencing, prenatal diagnosis

Citation

Tang H, Chen Q, Xiang J and Zhang Q (2025) Identification and splicing analysis of the first deep intronic FIG4 variant causing Yunis–Varon syndrome. Front. Genet. 16:1624122. doi: 10.3389/fgene.2025.1624122

Received

08 May 2025

Accepted

14 July 2025

Published

08 August 2025

Volume

16 - 2025

Edited by

Giulia Pascolini, Institute of Immaculate Dermatology (IRCCS), Italy

Reviewed by

Dora Janeth Fonseca, Rosario University, Colombia

Ke Wu, Quzhou Maternity and Child Health Care Hospital, China

Updates

Copyright

*Correspondence: Jingjing Xiang, ; Qin Zhang,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics